IL33 and inflammatory bowel disease: On the one hand, mucosal IL-33 levels correlated with disease severity in IBD patients and in mice with experimental colitis [158], and lack of IL-33 or ST2 attenuated dextran sodium sulfate-induced colitis by protection against IL-33-mediated epithelial damage [159] and enhanced wound healing response [160].